Variable | Mother-infant pairs ingested medication at birth | Unadjusted OR (95% CI) | Adjusted OR (95% CI) | |
---|---|---|---|---|
Yes n(%) | No n(%) | |||
Age in years | ||||
15-24 | 48(63.2) | 28(36.8) | 1 | |
25-29 | 60(69.8) | 26(30.2) | 1.35(0.64-2.85) | |
≥ 30 | 37(69.8) | 16(30.2) | 1.0(0.48-2.11) | |
Education (grade completed) | ||||
0-4 | 38(62.3) | 23(37.7) | 1 | |
5-8 | 55(70.5) | 23(29.5) | 0.69(0.34-1.41) | |
≥9 | 54(73.0) | 20(27.0) | 0.61(0.30-1.27) | |
Number of pregnancies | ||||
First | 48(69.6) | 21(30.4) | 1 | 1 |
Second | 59(73.8) | 21(26.3) | 0.81(0.40-1.66) | 0.60(0.27-1.34) |
Three or more | 39(58.2) | 28(41.8) | 1.64(0.81-3.32) | 1.34(0.62-2.87) |
Gestational age at enrolment | ||||
< 28 weeks | 78(64.5) | 43(35.5) | 1 | |
≥ 28 weeks | 47(71.2) | 19(28.8) | 0.7(0.38-1.40) | |
CD4 cell count/mm 3 | ||||
≥ 350 | 49(75.4) | 16(24.6) | 1 | |
200-349 | 31(67.4) | 15(32.6) | 2.08(0.90-4.80) | |
< 200 | 25(59.5) | 17(40.5) | 1.48(0.64-3.42) | |
Disclosed to partner | ||||
Yes | 110(71.9) | 43(28.1) | 1 | |
No | 19(63.3) | 11(36.7) | 1.48(0.65-3.37) | |
Medication initiated | ||||
ZDV prophylaxis | 101(74.8) | 34(25.2) | 1 | 1 |
Lifelong ART | 45(63.4) | 26(36.6) | 1.72(.92-3.19) | 1.85(0.96-3.56) |
Place of delivery | ||||
Health facility | 143(70.8) | 59(29.2) | 1 | 1 |
Home | 5(29.4) | 12(70.6) | 5.82(1.96-17.24) | 6.72(2.90-21.65) |